Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Rana

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
RSC Medicinal Chemistry|May 30, 2023
<i>Mycobacterium tuberculosis</i> CitA activity is modulated by cysteine oxidation and pyruvate bindingRasangi Pathirage, Lorenza Favrot, Cecile Petit, et al.
Chemical Biology & Drug Design|April 3, 2020
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDKSandeep Rana, Smit Kour, Yogesh A Sonawane, et al.
Chemical Communications (Cambridge, England)|May 12, 2021
Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive mannerJohn V Napoleon, Sarbjit Singh, Sandeep Rana, et al.
Neuro-Degenerative Diseases|November 20, 2013
Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control studyAngela M Malek, Aaron Barchowsky, Robert Bowser, et al.
Cancers|May 5, 2021
PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem CellsBalawant Kumar, Rizwan Ahmad, Swagat Sharma, et al.
Biomedicines|January 8, 2025
Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3Elizabeth Schmitz, Abigail Ridout, Audrey L Smith, et al.
Journal of Medicinal Chemistry|November 23, 2013
Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinaseTing Chen, Khuloud Takrouri, Sung Hee-Hwang, et al.
Chemical Communications (Cambridge, England)|June 22, 2017
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)Caroline M Robb, Jacob I Contreras, Smit Kour, et al.
Brain Research|December 13, 2006
Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicityHyun-Seok Hong, Izumi Maezawa, Nianhuan Yao, et al.
Plos One|March 30, 2021
Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interactionMona Al-Mugotir, Jeffrey J Lovelace, Joseph George, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
RSC Medicinal Chemistry|May 30, 2023
<i>Mycobacterium tuberculosis</i> CitA activity is modulated by cysteine oxidation and pyruvate bindingRasangi Pathirage, Lorenza Favrot, Cecile Petit, et al.
Chemical Biology & Drug Design|April 3, 2020
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDKSandeep Rana, Smit Kour, Yogesh A Sonawane, et al.
Chemical Communications (Cambridge, England)|May 12, 2021
Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive mannerJohn V Napoleon, Sarbjit Singh, Sandeep Rana, et al.
Neuro-Degenerative Diseases|November 20, 2013
Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control studyAngela M Malek, Aaron Barchowsky, Robert Bowser, et al.
Cancers|May 5, 2021
PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem CellsBalawant Kumar, Rizwan Ahmad, Swagat Sharma, et al.
Biomedicines|January 8, 2025
Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3Elizabeth Schmitz, Abigail Ridout, Audrey L Smith, et al.
Journal of Medicinal Chemistry|November 23, 2013
Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinaseTing Chen, Khuloud Takrouri, Sung Hee-Hwang, et al.
Chemical Communications (Cambridge, England)|June 22, 2017
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)Caroline M Robb, Jacob I Contreras, Smit Kour, et al.
Brain Research|December 13, 2006
Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicityHyun-Seok Hong, Izumi Maezawa, Nianhuan Yao, et al.
Plos One|March 30, 2021
Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interactionMona Al-Mugotir, Jeffrey J Lovelace, Joseph George, et al.
Pageof 8